+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Influenza Vaccines: Global Markets

  • PDF Icon

    Report

  • 109 Pages
  • May 2022
  • Region: Global
  • BCC Research
  • ID: 5596170
The report explains critical trends in the influenza vaccine industry. It discusses the market determinants, which act as motivating or restraining factors, and provides insights to stakeholders and potential entrants. This report study includes only human vaccines; animal vaccines have not been considered in this report. This study looks at most of the systems affected by factors such as considerable research and development spending and increasing competition and new technologies, which are giving direction to the market. These advancements, new product launches and changing lifestyles are influencing future market growth. Company merger acquisition strategies and collaborations are also covered in this report. Additionally, this study discusses the strengths and weaknesses of each strategy type considering new technologies, growing competition and changing customer needs. The market has also been analyzed based on the type of influenza vaccines. Categories considered in this report include inactivated vaccines and live-attenuated vaccines. This study details market growth among vaccine manufacturers and end users. Genomic research centers, academic institutions, government and private laboratories and various hospital settings, as well as pharmaceutical, diagnostic and biotechnology companies and physicians, will find this study to be of interest. The report provides useful information to all market players, potential entrants, government agencies and other interested parties. As the report covers geographic regions in detail, companies interested in expanding their geographic reach will also find this study useful.



Report Includes

  • 20 data tables and 29 additional tables
  • An updated overview of the global market for influenza vaccines within the biopharmaceutical industry
  • Analyses of the global market trends, with historic revenue (sales) data for 2019-2021, and projections of compound annual growth rates (CAGRs) through 2026
  • Evaluation and forecast the market size for influenza vaccines, and corresponding market share analysis by type, technology, age, and region
  • Information on baloxavir marboxil (Xofluza) vaccine, along with types of influenza virus strains used for vaccine preparation like influenza type A with H3N2 virus strain, influenza type A with H1N1 virus strain, and influenza type B virus strain
  • Country specific data and market value analysis for the U.S., Canada, Germany, U.K., France, Italy, Spain, Australia, Japan, China and India
  • Technology assessment of the key drivers, restraints and opportunities that will shape the market over the next five years (2021 to 2026)
  • Discussion of technology advancements in influenza vaccines development, product innovations, government regulations, clinical trials, and other key market strategies
  • Coverage of key merger acquisition strategies and collaboration agreements in the marketplace
  • In-depth information on increasing investments on R&D activities, key technology issues, industry specific challenges, major types of end-user markets, and COVID-19 implications on the progress of this market
  • Descriptive company profiles of the leading global players, including AstraZeneca, CSL Ltd., Abbott Laboratories, GlaxoSmithKline plc and Sanofi
Frequently Asked Questions about the Global Influenze Vaccines Market

What is the estimated value of the Global Influenze Vaccines Market?

The Global Influenze Vaccines Market was estimated to be valued at $6.9 Billion in 2021.

What is the growth rate of the Global Influenze Vaccines Market?

The growth rate of the Global Influenze Vaccines Market is 7.9%, with an estimated value of $10.1 Billion by 2026.

What is the forecasted size of the Global Influenze Vaccines Market?

The Global Influenze Vaccines Market is estimated to be worth $10.1 Billion by 2026.

Who are the key companies in the Global Influenze Vaccines Market?

Key companies in the Global Influenze Vaccines Market include Abbott Laboratories, Astrazeneca plc, Bharat Biotech International Ltd., Biodiem Ltd., Csl Ltd., Emergent Biosolutions Inc., Gc Biopharma (Green Cross Corp.), GlaxoSmithKline plc and Sanofi.

Table of Contents

Chapter 1 Introduction
  • Study Background
  • Study Goals and Objectives
  • Reasons for Doing this Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • Custom Research
  • Related Research Reports

Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
  • Definitions
  • Immune System and Vaccines
  • How Vaccines Work?
  • Influenza Vaccines - Overview
  • The Pathogen
  • Signs and Symptoms
  • Epidemiology
  • Diagnosis
  • Prevention
  • Type of Influenza Vaccines
  • Annual Selection of Viruses
  • Production
  • Inactivated Influenza Vaccines (Iivs)
  • Live-Attenuated Influenza Vaccines (Laivs)
  • Regulatory Aspects

Chapter 4 Impact of Covid-19
  • Overview
  • Impact of Covid-19 on the 2021-2022 Flu Season
  • Low Levels of Flu May Lead to Contentment About Getting the Vaccine
  • Positive Impact of Covid-19 on Flu Vaccination Rates
  • Influenza Vaccination Increased During the Covid-19 Pandemic

Chapter 5 Influenza Vaccines Market Dynamics
  • Market Drivers
  • Increase in Government Support and Surveillance Regarding Vaccination Against Influenza at the National and Global Levels
  • Growing Awareness of Immunization Across the Globe
  • The Rise in Investment by Top Market Players Across the Globe and Growth in Government Funding Has Facilitated the Launch of Therapeutically Effective Vaccines
  • Market Restraints
  • Stringent Regulatory Requirements Along With Prolonged Duration of Clinical Trials
  • Limited Adoption of Influenza Vaccines in Low- and Middle-Income Countries (Lmics)
  • Market Opportunities
  • Demand for Universal Flu Vaccines Fuels the Need to Develop Innovative Approaches for Vaccine Development
  • Competitive Landscape
  • Company Share Analysis

Chapter 6 Market Breakdown by Type
  • Global Influenza Vaccines Market, by Type
  • Inactivated Vaccines
  • Market Size and Forecast
  • Live-Attenuated Vaccines
  • Market Size and Forecast

Chapter 7 Market Breakdown by Technology
  • Global Influenza Vaccines Market, by Technology
  • Egg-Based
  • Market Size and Forecast
  • Cell-Based Vaccine
  • Market Size and Forecast

Chapter 8 Market Breakdown by Age
  • Global Influenza Vaccines Market, by Age
  • Pediatric
  • Market Size and Forecast
  • Adults
  • Among Adults, Who Should Not Get the Flu Vaccine?
  • Market Size and Forecast

Chapter 9 Market Breakdown by Region
  • Global Influenza Vaccines Market, by Region
  • North America
  • U.S.
  • Canada
  • Europe
  • National Recommendations Across Europe
  • Achieved Coverage
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • Australia
  • India
  • Rest of Asia-Pacific
  • Rest of the World
  • Market Size and Forecast

Chapter 10 Company Profiles
  • Abbott Laboratories
  • Astrazeneca plc
  • Biodiem Ltd.
  • Bharat Biotech International Ltd.
  • Csl Ltd.
  • Emergent Biosolutions Inc.
  • GlaxoSmithKline plc
  • Gc Biopharma (Green Cross Corp.)
  • Novavax Inc.
  • Sanofi
  • Sinovac Biotech Ltd.

Chapter 11 Appendix: List of Abbreviations
List of Tables
Summary Table: Global Influenza Vaccines Market, by Type, Through 2026
Table 1: Seasonal Influenza Vaccines
Table 2: U.S. Influenza Vaccines for the 2021-2022 Influenza Season
Table 3: Global Influenza Vaccines Market, by Type, Through 2026
Table 4: Global Inactivated Influenza Vaccines Market, by Region, Through 2026
Table 5: Global Live-attenuated Influenza Vaccines Market, by Region, Through 2026
Table 6: Global Influenza Vaccines Market, by Technology, Through 2026
Table 7: Egg-based Influenza Vaccine Products for 2021-2022 Influenza Season
Table 8: Global Egg-based Influenza Vaccines Market, by Region, Through 2026
Table 9: Global Cell-based Influenza Vaccines Market, by Region, Through 2026
Table 10: Global Influenza Vaccines Market, by Age, Through 2026
Table 11: Influenza Vaccines by Age
Table 12: Influenza Vaccine Price List, 2020
Table 13: Global Market for Pediatrics in Influenza Vaccines, by Region, Through 2026
Table 14: Global Market for Adults in Influenza Vaccines, by Region, Through 2026
Table 15: Global Influenza Vaccines Market, by Region, Through 2026
Table 16: North American Influenza Vaccines Market, by Type, Through 2026
Table 17: North American Influenza Vaccines Market, by Country, Through 2026
Table 18: U.S. Cumulative 2021/2022 Season Lot Release Status (Updated 11/3/2021)
Table 19: Overview of Available Seasonal Influenza Vaccines in the E.U./E.E.A.
Table 20: European Influenza Vaccines Market, by Type, Through 2026
Table 21: European Influenza Vaccines Market, by Country, Through 2026
Table 22: Influenza Vaccines Marketed in the U.K. for the 2022-2023 Influenza Season
Table 23: Asia-Pacific Influenza Vaccines Market, by Type, Through 2026
Table 24: Asia-Pacific Influenza Vaccines Market, by Country, Through 2026
Table 25: Rest of the World Influenza Vaccines Market, by Type, Through 2026
Table 26: Abbott Laboratories: Vaccines Offered
Table 27: AstraZeneca: Vaccines Offered
Table 28: AstraZeneca: Recent Developments
Table 29: BioDiem Ltd.: Vaccines Offered
Table 30: BioDiem Ltd.: Recent Developments
Table 31: Bharat Biotech: Vaccines Offered
Table 32: Bharat Biotech: Recent Developments
Table 33: CSL Ltd. (Seqirus): Vaccines Offered
Table 34: CSL Ltd. (Seqirus): Recent Developments
Table 35: Emergent BioSolutions Inc.: Vaccines Offered
Table 36: Emergent BioSolutions Inc.: Recent Developments
Table 37: GlaxoSmithKline plc: Vaccines Offered
Table 38: GlaxoSmithKline plc: Flu Vaccines Sales, 2019-2020
Table 39: GlaxoSmithKline plc: Recent Developments
Table 40: GC Biopharma: Vaccines Offered
Table 41: GC Biopharma: Recent Developments
Table 42: Novavax Inc.: Vaccines Offered
Table 43: Novavax Inc.: Recent Developments
Table 44: Sanofi: Vaccines Offered
Table 45: Sanofi: Recent Developments
Table 46: Sinovac Biotech Ltd.: Vaccines Offered
Table 47: Sinovac Biotech Ltd.: Recent Developments
Table 48: Abbreviations Used in the Vaccine Technologies Market
List of Figures
Summary Figure: Global Influenza Vaccines Market Share, by Type, 2020
Figure 1: Timeline of Influenza Vaccine History
Figure 2: Global Influenza Vaccines Market Share, by Companies, 2020
Figure 3: Global Influenza Vaccines Market Share, by Type, 2020
Figure 4: Global Inactivated Influenza Vaccines Market, 2019-2026
Figure 5: Global Inactivated Influenza Vaccines Market, by Region, 2019-2026
Figure 6: Global Live-attenuated Influenza Vaccines Market, 2019-2026
Figure 7: Global Live-attenuated Influenza Vaccines Market, by Region, 2019-2026
Figure 8: Global Market Share for Influenza Vaccines, by Technology, 2020
Figure 9: Global Egg-based Influenza Vaccines Market, 2019-2026
Figure 10: Global Egg-based Influenza Vaccines Market, by Region, 2019-2026
Figure 11: Evolution of Influenza Vaccine Substrates from Embryonated Eggs to Cells
Figure 12: Global Cell-based Influenza Vaccines Market, 2019-2026
Figure 13: Global Cell-based Influenza Vaccines Market, by Region, 2019-2026
Figure 14: Global Market Share for Influenza Vaccines, by Age, 2020
Figure 15: Global Market for Pediatrics in Influenza Vaccines, 2019-2026
Figure 16: Global Market for Pediatrics in Influenza Vaccines, by Region, 2019-2026
Figure 17: Global Market for Adults in Influenza Vaccines, 2019-2026
Figure 18: Global Market for Adults in Influenza Vaccines, by Region, 2019-2026
Figure 19: Global Influenza Vaccines Market, by Region, 2019-2026
Figure 20: Global Influenza Vaccines Market Share, by Region, 2020
Figure 21: North American Influenza Vaccines Market Share, by Technology, 2020
Figure 22: North American Influenza Vaccines Market Share, by Country, 2020
Figure 23: U.S. Influenza Vaccines Market, 2019-2026
Figure 24: Canadian Seasonal Flu Vaccination Coverage, 2018-2019 to 2020-2021 Flu Seasons
Figure 25: Canadian Influenza Vaccines Market, 2019-2026
Figure 26: European Influenza Vaccines Market Share, by Type, 2020
Figure 27: European Influenza Vaccines Market Share, by Country, 2020
Figure 28: German Influenza Vaccines Market, 2019-2026
Figure 29: French Influenza Vaccines Market, 2019-2026
Figure 30: U.K. Influenza Vaccines Market, 2019-2026
Figure 31: Italian Influenza Vaccines Market, 2019-2026
Figure 32: Spanish Influenza Vaccines Market, 2019-2026
Figure 33: Rest of the European Influenza Vaccines Market, 2019-2026
Figure 34: Asia-Pacific Influenza Vaccines Market Share, by Type, 2020
Figure 35: Asia-Pacific Influenza Vaccines Market Share, by Country, 2020
Figure 36: Chinese Influenza Vaccines Market, 2019-2026
Figure 37: Japanese Influenza Vaccines Market, 2019-2026
Figure 38: Australian Influenza Vaccines Market, 2019-2026
Figure 39: Indian Influenza Vaccines Market, 2019-2026
Figure 40: Rest of Asia-Pacific Influenza Vaccines Market, 2019-2026
Figure 41: Rest of the World Influenza Vaccines Market Share, by Type, 2020
Figure 42: Abbott Laboratories: Net Revenue, 2016-2020
Figure 43: Abbott Laboratories: Revenue Share, by Business Segment, 2020
Figure 44: Abbott Laboratories: Revenue Share, by Country, 2020
Figure 45: AstraZeneca: Net Revenue, 2017-2021
Figure 46: AstraZeneca: Revenue Share, by Business Segment, 2021
Figure 47: AstraZeneca: Revenue Share, by Region, 2021
Figure 48: CSL Ltd. (Seqirus): Net Revenue, 2017-2021
Figure 49: CSL Ltd. (Seqirus): Revenue Share, by Business Segment, 2021
Figure 50: Emergent BioSolutions Inc.: Net Revenue, 2016-2020
Figure 51: GlaxoSmithKline plc: Net Revenue, 2016-2020
Figure 52: GlaxoSmithKline plc: Revenue Share, by Business Segment, 2020
Figure 53: GlaxoSmithKline plc: Revenue Share, by Region, 2020
Figure 54: Novavax Inc.: Net Revenue, 2016-2020
Figure 55: Novavax Inc.: Revenue Share, by Business Segment, 2020
Figure 56: Novavax Inc.: Revenue Share, by Region, 2020
Figure 57: Sanofi: Net Revenue, 2017-2021
Figure 58: Sanofi: Revenue Share, by Business Segment, 2021
Figure 59: Sanofi: Revenue Share, by Region, 2021

Executive Summary

The fast growth rate of the inactivated vaccines is attributed to increasing company investments in IIV development and the excellent stability profile of this vaccine type, which has a proven record of safety and immune response.

The global influenza vaccines market is segmented in this report by type, technology, age and region.

Reasons for Doing This Study:


The World Health Organization estimates that seasonal influenza may result in 290,000 to 650,000 deaths annually due to respiratory diseases alone. There are several reasons to get the influenza (flu) vaccine each year. Flu vaccination is the best way to obtain protection against flu and possibly severe complications. Flu vaccinations avoid millions of instances of illness and flu-related doctor’s visits each year. For instance, during 2019-2020, flu vaccination averted a projected 7.5 million instances of influenza illnesses, 3.7 million influenza-related medical visits, 105,000 influenza-associated hospitalizations and 6,300 influenza-associated fatalities. Vaccination is one of the most cost-effective
ways to reduce the seasonal influenza disease load. The overall increase in infectious and noninfectious diseases, growing population, technological advancements and continuous innovations are creating a considerable scope for the influenza vaccines market. The resurgence of vaccine-preventable diseases and the emergence of new pandemics and immunization programs in emerging economies also influence the global influenza vaccines market. This report is designed to be a critical decision-making tool for the intended audience, including influenza vaccine manufacturing players, potential market entrants and other professionals involved with or interested in immunology and vaccine-preventable seasonal influenza.

Companies Mentioned

  • Abbott Laboratories
  • Astrazeneca plc
  • Bharat Biotech International Ltd.
  • Biodiem Ltd.
  • Csl Ltd.
  • Emergent Biosolutions Inc.
  • Gc Biopharma (Green Cross Corp.)
  • GlaxoSmithKline plc
  • Novavax Inc.
  • Sanofi
  • Sinovac Biotech Ltd.